Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice

被引：9
|
作者：
Tovey, E
Rampes, H
Livingstone, C
机构：
[1] Barnet Enfield & Haringey Mental Hlth NHS Trust, NW Community Mentel Hlth Team, Edgware HA8 7BJ, Middx, England
[2] Royal Surrey Cty Hosp, Dept Clin Biochem, Guildford, Surrey, England
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2005年 / 19卷 / 02期
关键词：
adverse effect; antipsychotic; clozapine; diabetes mellitus; schizoaffective disorder; schizophrenia;
D O I：
10.1177/0269881105049043
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The atypical antipsychotic clozapine has been reported to be associated with metabolic adverse effects, including type-2 diabetes mellitus. We present two cases of diabetes mellitus associated with clozapine treatment. One case resolved entirely upon withdrawal of the drug, whereas the other did not. We discuss the molecular basis of the diabetogenic action of clozapine and recommendations for monitoring.
引用
收藏
页码：207 / 210
页数：4
相关论文
共 50 条
  • [31] Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice
    Kristina M. Utzschneider
    Kris V. Kowdley
    Nature Reviews Endocrinology, 2010, 6 : 26 - 33
  • [32] The natural history of type 2 diabetes - Implications for clinical practice
    Ramlo-Halsted, BA
    Edelman, SV
    PRIMARY CARE, 1999, 26 (04): : 771 - +
  • [33] Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
    Huang, Chunmei
    Florez, Jose C.
    GENOME MEDICINE, 2011, 3
  • [34] Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
    Chunmei Huang
    Jose C Florez
    Genome Medicine, 3
  • [35] Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significance
    Su, Hui
    Lau, Wayne Bond
    Ma, Xin-Liang
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (12) : 897 - 904
  • [36] THE PREVALENCE OF HYPOGONADISM IN MEN WITH TYPE 2 DIABETES MELLITUS IN CLINICAL PRACTICE
    Melnichenko, Galina A.
    Shestakova, Marina V.
    Rozhivanov, Roman V.
    DIABETES MELLITUS, 2019, 22 (02): : 127 - 130
  • [37] Clinical practice guidelines on diabetes mellitus and pregnancy: Ι. Pre-existing type 1 and type 2 diabetes mellitus
    Eleni Anastasiou
    Georgios Farmakidis
    Angeliki Gerede
    Dimitrios G. Goulis
    Eftychia Koukkou
    Anargyros Kourtis
    Apostolos Mamopoulos
    Kasiani Papadimitriou
    Vasilios Papadopoulos
    Theodoros Stefos
    Hormones, 2020, 19 : 593 - 600
  • [38] Clinical practice guidelines on diabetes mellitus and pregnancy: Ι. Pre-existing type 1 and type 2 diabetes mellitus
    Anastasiou, Eleni
    Farmakidis, Georgios
    Gerede, Angeliki
    Goulis, Dimitrios G.
    Koukkou, Eftychia
    Kourtis, Anargyros
    Mamopoulos, Apostolos
    Papadimitriou, Kasiani
    Papadopoulos, Vasilios
    Stefos, Theodoros
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 19 (04): : 593 - 600
  • [39] 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
    Kim, Mee Kyoung
    Ko, Seung-Hyun
    Kim, Bo-Yeon
    Kang, Eun Seok
    Noh, Junghyun
    Kim, Soo-Kyung
    Park, Seok-O
    Hur, Kyu Yeon
    Chon, Suk
    Moon, Min Kyong
    Kim, Nan-Hee
    Kim, Sang Yong
    Rhee, Sang Youl
    Lee, Kang-Woo
    Kim, Jae Hyeon
    Rhee, Eun-Jung
    Chun, SungWan
    Yu, Sung Hoon
    Kim, Dae Jung
    Kwon, Hyuk-Sang
    Park, Kyong Soo
    DIABETES & METABOLISM JOURNAL, 2019, 43 (04) : 398 - 406
  • [40] INSTITUTIONAL CLINICAL PRACTICE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN MEXICO
    Juarez-Garcia, A.
    Vargas-Valencia, J.
    Martinez-Rivera, G.
    Sotelo-Guzman, M.
    Elias-Lopez, J., I
    Zamora-Barron, M.
    Rangel, S.
    VALUE IN HEALTH, 2011, 14 (07) : A556 - A556
12345